Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-30T23:42:03.713Z Has data issue: false hasContentIssue false

Outcomes of cardiac surgery in trisomy 18 patients

Published online by Cambridge University Press:  21 December 2010

Jun Muneuchi*
Affiliation:
Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Junko Yamamoto
Affiliation:
Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Yasuhiko Takahashi
Affiliation:
Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Mamie Watanabe
Affiliation:
Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Tetsuji Yuge
Affiliation:
Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Takuro Ohno
Affiliation:
Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Yutaka Imoto
Affiliation:
Department of Cardiovascular Surgery, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Akira Sese
Affiliation:
Department of Cardiovascular Surgery, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
Kunitaka Joo
Affiliation:
Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan
*
Corresponding to: Dr J. Muneuchi, Division of Pediatrics, Kyushu Koseinenkin Hospital, 1-8-1, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka 806-8501, Japan. Tel: +81 93 641 5111; Fax: +81 93 642 1868; E-mail: [email protected]

Abstract

Objective

The objective was to clarify the outcomes of cardiac surgery in trisomy 18 patients.

Patients and methods

We analysed 34 consecutive trisomy 18 patients, of whom 21 were males, with cardiac complications. They were divided into patients who underwent cardiac surgery and those who were conservatively treated. We compared rates of survival and discharge alive between two groups.

Results

The surgery group included nine patients, with six males, who underwent cardiac surgery – intracardiac repair in three patients, pulmonary arterial banding in five patients, and ligation of the ductus in one patient – at median age of 2.2 months, ranging from 0.5 to 9.8, and with median weight of 2.6 kilograms, ranging from 1.5 to 3.2. Cardiac surgery and pre-operative assisted ventilation were hazardous factors leading to death. In the surgery group, cumulative survival rates at 1 month, 6 months, 12 months, and 24 months were 63%, 38%, 25%, and 22%, respectively, compared with 51%, 26%, 9%, and 9% in the conservative group. There was a significant difference (p = 0.002). The cumulative rates of discharge alive at 1 month, 3 months, and 6 months were 0%, 12%, and 65% in the surgery group, which did not differ from the conservative group (p = 0.80).

Conclusions

Cardiac surgery contributed to increased survival rate but not the rate of discharge alive in trisomy 18 patients. Cardiac surgery could not prevent all the trisomy 18 patients from death. The indication of cardiac surgery should be carefully individualised to improve the quality of life in trisomy 18 patients and concerned surrounding people.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Embleton, ND, Wyllie, JP, Wright, MJ, Burn, J, Hunter, S. Natural history of trisomy 18. Arch Dis Child 1996; 75: F38F41.CrossRefGoogle ScholarPubMed
2. Root, S, Carey, JC. Survival in trisomy 18. Am J Med Genet 1994; 49: 170174.CrossRefGoogle ScholarPubMed
3. Rasmussen, SA, Wong, LYC, Yang, QY, May, KM, Friedman, JM. Population-based analysis of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111: 777784.CrossRefGoogle ScholarPubMed
4. Niedrist, D, Riegel, M, Achermann, J, Schinzel, A. Survival with trisomy 18-Data from Switzerland. Am J Med Genet A 2006; 140: 952959.CrossRefGoogle ScholarPubMed
5. Brewer, CM, Holloway, SH, Stone, DH, Carothers, AD, FitzPatrick, DR. Survival in trisomy 13 and trisomy 18 cases ascertained from population based registers. J Med Genet 2002; 39: e54.CrossRefGoogle ScholarPubMed
6. American Heart Association, American Academy of Pediatrics. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: neonatal resuscitation guidelines. Pediatrics 2006; 117: e1029e1038.CrossRefGoogle Scholar
7. Carey, JC. Trisomy 18 and trisomy 13 syndrome. In: Cassey SB, Allanson JE (eds.). Management of Genetic Syndromes, 2nd edn. Wiley & Sons Inc., Hoboken, NJ, 2005; 555568.Google Scholar
8. Matsuoka, R, Misugi, K, Goto, A, Gilbert, EF, Ando, M. Congenital heart anomalies in the trisomy 18 syndrome, with reference to congenital polyvalvular disease. Am J Med Genet 1983; 14: 657668.CrossRefGoogle ScholarPubMed
9. Graham, EM, Bradley, SM, Shirali, GS, Hills, CB, Atz, AM. Effectiveness of cardiac surgery in trisomy 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol 2004; 93: 801803.CrossRefGoogle ScholarPubMed
10. Kaneko, Y, Kobayashi, J, Achiwa, I, et al. Cardiac surgery in patients with trisomy 18. Pediatr Cardiol 2009; 30: 729734.CrossRefGoogle ScholarPubMed
11. Kosho, T, Nakamura, T, Kawame, H, Baba, A, Tamura, M, Fukushima, Y. Neonatal management of trisomy 18: details of 24 patients receiving intensive treatment. Am J Med Genet A 2006; 140: 937944.CrossRefGoogle ScholarPubMed
12. Kinoshita, M, Nakamura, Y, Nakano, R, et al. Thirty-one autopsy cases of trisomy 18: clinical features and pathological findings. Pediatr Pathol 1989; 9: 445457.CrossRefGoogle ScholarPubMed
13. Baty, BJ, Blackburn, BL, Carey, JC. Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 1994; 49: 175188.CrossRefGoogle ScholarPubMed
14. Chervenak, FA, McCullough, LB. An ethically justified, clinically comprehensive management strategy for third trimester pregnancies complicated by fetal anomalies. Obstet Gynecol 1990; 75: 311316.Google ScholarPubMed